Search Results - "Kornetova, Elena G."

Cytokines as Potential Biomarkers of Clinical Characteristics of Schizophrenia by Mednova, Irina A, Boiko, Anastasiia S, Kornetova, Elena G, Semke, Arkadiy V, Bokhan, Nikolay A, Ivanova, Svetlana A

“…Immune activation plays a major role in the pathogenesis of schizophrenia, as confirmed by many studies, systematic reviews, and meta-analyses. The important…”
Get full text

Serum Growth Factors in Schizophrenia Patients by Boiko, Anastasiia S, Mednova, Irina A, Kornetova, Elena G, Bokhan, Nikolay A, Ivanova, Svetlana A

“…Some hypotheses include schizophrenia as a neurodevelopmental disorder, which indicates a special role in growth factors and neuroglia in the development of…”
Get full text

Global hypomyelination of the brain white and gray matter in schizophrenia: quantitative imaging using macromolecular proton fraction by Smirnova, Liudmila P., Yarnykh, Vasily L., Parshukova, Daria A., Kornetova, Elena G., Semke, Arkadiy V., Usova, Anna V., Pishchelko, Anna O., Khodanovich, Marina Y., Ivanova, Svetlana A.

“…Myelin deficiency is commonly recognized as an important pathological feature of brain tissues in schizophrenia (SZ). In this pilot study, global myelin…”
Get full text

Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics by Boiko, Anastasiia S., Mednova, Irina A., Kornetova, Elena G., Gerasimova, Valeria I., Kornetov, Alexander N., Loonen, Anton J. M., Bokhan, Nikolay A., Ivanova, Svetlana A.

“…The present study aims at comparing the change in cytokine levels in schizophrenia patients treated with atypical antipsychotics, with or without metabolic…”
Get full text

Study of Early Onset Schizophrenia: Associations of GRIN2A and GRIN2B Polymorphisms by Poltavskaya, Evgeniya G., Fedorenko, Olga Yu, Kornetova, Elena G., Loonen, Anton J. M., Kornetov, Alexander N., Bokhan, Nikolay A., Ivanova, Svetlana A.

“…Background: Schizophrenia is a complex mental disorder with a high heritability. Dysfunction of the N-methyl-D-aspartate (NMDA)-type glutamate receptors may be…”
Get full text

Igg-Dependent Hydrolysis of Myelin Basic Protein of Patients with Different Courses of Schizophrenia by Buneva, Valentina N., Semke, Arkadiy V., Kornetova, Elena G., Smirnova, Liudmila P., Parshukova, Daria A., Ivanova, Svetlana A.

“…The level hydrolysis of myelin basic protein (MBP) by IgG in patients with schizophrenia was studied depending on the clinical features and course of the…”
Get full text

Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome by Kornetova, Elena G., Kornetov, Alexander N., Mednova, Irina A., Dubrovskaya, Viktoria V., Boiko, Anastasia S., Bokhan, Nikolay A., Loonen, Anton J. M., Ivanova, Svetlana A.

“…Background: Metabolic syndrome (MetS) is a common problem in schizophrenia patients and associated with increased mortality due to cardiovascular disease…”
Get full text

Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia by Boiko, Anastasiia S., Mednova, Irina A., Kornetova, Elena G., Semke, Arkadiy V., Bokhan, Nikolay A., Loonen, Anton J.M., Ivanova, Svetlana A.

“…Schizophrenia is associated with a lowered life expectancy due to cardiovascular disease. This is, at least in part, related to an increased vulnerability to…”
Get full text

Genetic polymorphisms of PIP5K2A and course of schizophrenia by Poltavskaya, Evgeniya G, Fedorenko, Olga Yu, Vyalova, Natalya M, Kornetova, Elena G, Bokhan, Nikolay A, Loonen, Anton J M, Ivanova, Svetlana A

“…Schizophrenia is a severe highly heritable mental disorder. The clinical heterogeneity of schizophrenia is expressed in the difference in the leading symptoms…”
Get full text

Comparative Characteristics of the Metabolic Syndrome Prevalence in Patients With Schizophrenia in Three Western Siberia Psychiatric Hospitals by Kornetova, Elena G., Kornetov, Alexander N., Mednova, Irina A., Goncharova, Anastasia A., Gerasimova, Valeria I., Pozhidaev, Ivan V., Boiko, Anastasiia S., Semke, Arkadiy V., Loonen, Anton J. M., Bokhan, Nikolay A., Ivanova, Svetlana A.

“…Objective: The purpose of this study was to compare the prevalence of MetS and the associated sociodemographic, clinical, and pharmacotherapeutic…”
Get full text

Adipocytokines and Metabolic Syndrome in Patients with Schizophrenia by Mednova, Irina A, Boiko, Anastasiia S, Kornetova, Elena G, Parshukova, Daria A, Semke, Arkadiy V, Bokhan, Nikolay A, Loonen, Anton J M, Ivanova, Svetlana A

“…The adipokines leptin, adiponectin, tumor necrosis factor-alpha (TNF-α), and interleukin 6 (IL-6) might be associated with metabolic syndrome (MetS) in…”
Get full text

Building Predictive Models for Schizophrenia Diagnosis with Peripheral Inflammatory Biomarkers by Kozyrev, Evgeny A, Ermakov, Evgeny A, Boiko, Anastasiia S, Mednova, Irina A, Kornetova, Elena G, Bokhan, Nikolay A, Ivanova, Svetlana A

“…Machine learning and artificial intelligence technologies are known to be a convenient tool for analyzing multi-domain data in precision psychiatry. In the…”
Get full text

Levels of Acylcarnitines and Branched-Chain Amino Acids in Antipsychotic-Treated Patients with Paranoid Schizophrenia with Metabolic Syndrome by Mednova, Irina A, Chernonosov, Alexander A, Kornetova, Elena G, Semke, Arkadiy V, Bokhan, Nikolay A, Koval, Vladimir V, Ivanova, Svetlana A

“…Several studies have shown that patients with schizophrenia are at high risk for metabolic syndrome (MetS) and bioenergetic dysfunction. Because acylcarnitines…”
Get full text

A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia by Osmanova, Diana Z, Freidin, Maxim B, Fedorenko, Olga Yu, Pozhidaev, Ivan V, Boiko, Anastasiia S, Vyalova, Natalia M, Tiguntsev, Vladimir V, Kornetova, Elena G, Loonen, Anton J M, Semke, Arkadiy V, Wilffert, Bob, Bokhan, Nikolay A, Ivanova, Svetlana A

“…Hyperprolactinemia (HPRL) is a classical side effect of antipsychotic drugs primarily attributed to blockade of dopamine D2 receptors (DRD2s) on the membranes…”
Get full text

Cell Adhesion Molecules in Schizophrenia Patients with Metabolic Syndrome by Boiko, Anastasiia S, Mednova, Irina A, Kornetova, Elena G, Semke, Arkadiy V, Bokhan, Nikolay A, Ivanova, Svetlana A

“…Metabolic syndrome (MetS) is a common comorbidity of schizophrenia and significantly shortens life expectancy of the patients. Intercellular (ICAM), vascular…”
Get full text

5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia by Pozhidaev, Ivan V, Paderina, Diana Z, Fedorenko, Olga Yu, Kornetova, Elena G, Semke, Arkadiy V, Loonen, Anton J M, Bokhan, Nikolay A, Wilffert, Bob, Ivanova, Svetlana A

“…Tardive dyskinesia (TD) is a common side effect of antipsychotic treatment. This movement disorder consists of orofacial and limb-truncal components. The…”
Get full text

The Influence of Antipsychotic Treatment on the Activity of Abzymes Targeting Myelin and Levels of Inflammation Markers in Patients with Schizophrenia by Kamaeva, Daria A, Kazantseva, Daria V, Boiko, Anastasiia S, Mednova, Irina A, Smirnova, Liudmila P, Kornetova, Elena G, Ivanova, Svetlana A

“…Catalytic antibodies, or abzymes, are capable of not only binding but also hydrolyzing various proteins. Previously, an increase in the level of myelin basic…”
Get full text

NOS1AP Gene Variants and Their Role in Metabolic Syndrome: A Study of Patients with Schizophrenia by Mednova, Irina A, Pozhidaev, Ivan V, Tiguntsev, Vladimir V, Bocharova, Anna V, Paderina, Diana Z, Boiko, Anastasiia S, Fedorenko, Olga Y, Kornetova, Elena G, Bokhan, Nikolay A, Stepanov, Vadim A, Ivanova, Svetlana A

“…Metabolic syndrome (MetS) is common among schizophrenia patients, and one of MetS's causes may be an imbalance in nitric oxide regulation. In this study, we…”
Get full text

Amino Acid and Acylcarnitine Levels in Chronic Patients with Schizophrenia: A Preliminary Study by Mednova, Irina A, Chernonosov, Alexander A, Kasakin, Marat F, Kornetova, Elena G, Semke, Arkadiy V, Bokhan, Nikolay A, Koval, Vladimir V, Ivanova, Svetlana A

“…Amino acids and acylcarnitines play an important role as substrates and intermediate products in most of pathways involved in schizophrenia development such as…”
Get full text

Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia by Fedorenko, Olga Yu, Paderina, Diana Z., Kornetova, Elena G., Poltavskaya, Evgeniya G., Pozhidaev, Ivan V., Goncharova, Anastasiia A., Freidin, Maxim B., Bocharova, Anna V., Bokhan, Nikolay A., Loonen, Anton J. M., Ivanova, Svetlana A.

“…Background: Tardive dyskinesia (TD) is an extrapyramidal side effect of the long-term use of antipsychotics. In the present study, the role of glutamatergic…”
Get full text